retatrutide approved by fda New Weight Loss Drug Retatrutide: My Patient's 85-Pound Journey (And What the Trials Don't Tirzepatide vs. Retatrutide | AlphaMan
Description
Most patients self-administer once weekly into the abdomen, thigh or upper arm

12/01/2017 Print issue publication Footnotes Conflict of interest: D.J
Patients with renal or hepatic impairment may require closer monitoring, especially if significant gastrointestinal symptoms lead to dehydration
10.1007/s001250050949 [DOI] [PubMed] [Google Scholar] Korsatko S., Jensen L., Brunner M., Sach-Friedl S., Tarp M

Each drop delivers 2500IU of D3 in a base of organic coconut oil for maximum absorption
Long-Term Results (13 years): Sustained weight loss of 1015% is typical, with results peaking around 1218 months